Literature DB >> 2469705

High-dosage intravenous gamma globulin: therapeutic failure in pemphigus and pemphigoid.

G Tappeiner1, A Steiner.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2469705     DOI： 10.1016/s0190-9622(89)80148-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.

Authors:  S Jolles
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 2.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Treatment of subepidermal immunobullous diseases.

Authors:  Donna A Culton; Luis A Diaz
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 4.  [Optimizing therapy in patients with severe autoimmune blistering skin diseases].

Authors:  E Schmidt
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

Review 5.  High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.

Authors:  Norito Ishii; Takashi Hashimoto; Detlef Zillikens; Ralf J Ludwig
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.